Finance

Lists
Why is 300142 down 5,18%?
Dive Deeper
300142:SHE
Walvax Biotechnology Co Ltd
CNÂ¥13,35
-5,18%
(-0,73) 1D
14 Okt., 15:04:25 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300142...
Open
CNÂ¥13,90
High
CNÂ¥13,91
Low
CNÂ¥13,30
Mkt. cap
22,47 mjd
Avg. vol.
112,32 m
Volume
81,23 m
Dividend
1,16%
Quarterly dividend
CNÂ¥0,04
Ex-dividend date
24 Jun. 2026
P/E ratio
114,76
52-wk high
CNÂ¥16,97
52-wk low
CNÂ¥10,88
EPS
CNÂ¥0,12
Shares outstanding
1,60 mjd
No. of employees
2 k
Open
CNÂ¥13,90
High
CNÂ¥13,91
Low
CNÂ¥13,30
Mkt. cap
22,47 mjd
Avg. vol.
112,32 m
Volume
81,23 m
Dividend
1,16%
Quarterly dividend
CNÂ¥0,04
Ex-dividend date
24 Jun. 2026
P/E ratio
114,76
52-wk high
CNÂ¥16,97
52-wk low
CNÂ¥10,88
EPS
CNÂ¥0,12
Shares outstanding
1,60 mjd
No. of employees
2 k
News stories
From web sources and news partners
About Walvax Biotechnology Co Ltd
CEO-
Employees1,98 k
Founded16 Jan. 2001
Headquarters-
Sector-
Websitewalvax.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
564,60 m
699,43 m
443,85 m
390,37 m
Cost of goods sold
91,98 m
145,27 m
139,96 m
131,33 m
Cost of revenue
91,98 m
145,27 m
139,96 m
131,33 m
Research and development expenses
94,96 m
76,11 m
43,80 m
64,16 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
286,83 m
411,46 m
214,69 m
197,11 m
Operating expense
404,88 m
550,98 m
154,28 m
287,67 m
Total operating expenses
496,86 m
696,25 m
294,24 m
419,00 m
Operating income
67,74 m
3,18 m
149,60 m
-28,63 m
Other non operating income
-2,25 m
3,49 m
-4,78 m
4,41 m
EBT including unusual items
124,24 m
29,83 m
128,94 m
-59,73 m
EBT excluding unusual items
83,99 m
11,22 m
143,66 m
-35,62 m
Income tax expense
13,63 m
8,19 m
14,52 m
8,74 m
Effective tax rate
10,97%
27,45%
11,26%
-14,64%
Other operating expenses
-1,00 m
108,29 k
-1,54 m
32,11 k
Net income
120,28 m
14,30 m
110,68 m
-56,48 m
Net profit margin
21,30%
2,04%
24,94%
-14,47%
Earnings per share
-
-
-
-
Interest and investment income
18,98 m
8,09 m
6,13 m
4,89 m
Interest expense
-
-906,16 k
-7,06 m
-9,61 m
Net interest expenses
18,98 m
7,18 m
-931,24 k
-4,72 m
Depreciation and amortization charges
-
-
-
-
EBITDA
158,64 m
98,50 m
244,92 m
55,24 m
Gain or loss from assets sale
130,39 k
-81,07 k
-
-351,32 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme